Hyperactivation of MAPK signaling similarly inhibited IL-12 production and TH1 stimulation by melanoma-altered DC, though these effects were independent of IL-10, TGFβ, VEGF, and PGE2 in tumor lysates (97). Here, TGFB1 is linked to melanoma.